Format

Send to

Choose Destination
See comment in PubMed Commons below
Clin Exp Pharmacol Physiol. 2007 Aug;34(8):814-21.

Ageing, oestrogen, platelets and thrombotic risk.

Author information

1
Department of Surgery, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA. miller.virginia@mayo.edu

Abstract

1. Adverse thrombotic cardiovascular events increase in women coincident with the onset of menopause. 2. Age past menopause may be an important variable in defining the benefit/risk of hormone treatments. 3. Few studies have examined hormonal status as a variable of ageing using a polygenomic approach of both humoral and cellular components of the coagulation system. 4. Longitudinal studies of a global set of platelet functions that define procoagulant activity (i.e. adhesion, aggregation, secretion and thrombin production) in individuals with documented hormonal status are needed to better understand how hormonal changes associated with ageing impact thrombotic risk.

[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wiley
    Loading ...
    Support Center